Resource library search

The UK is a world leader in biofilm research and innovation. To further progress, the UK government should consider several actions, such as providing sustained funding for interdisciplinary research hubs and ensuring researchers have access to critical infrastructure and training.

The UK Parliament’s Environmental Audit Committee has launched its ‘The Environment in Focus’ inquiry, inviting proposals on what the Committee should investigate next in the areas of climate change, the environment and nature.

Microbes do not exist in isolation. Instead, they live in complex and dynamic communities in which different microbial species are constantly interacting.

As Ireland’s Second One Health Nation Action Plan (iNAP2) on AMR concludes, the Microbiology Society urges a stronger role for researchers in shaping the next phase of national policy. These recommendations are based on views gathered from its community of Irish microbiologists through a series of workshops and surveys held in November and December 2024. The aim was to assess the current AMR research and development (R&D) landscape in Ireland and guide the formation of the upcoming iNAP3.

The House of Commons Science, Innovation and Technology Committee launched an inquiry on what MPs should put under the microscope. In other words, the committee called for input on the questions they should be exploring and how the government can ensure that science and technology do good for people across the United Kingdom.

The Microbiology Society has submitted evidence to the UK Parliament’s Public Accounts Committee (PAC) inquiry into antimicrobial resistance (AMR), highlighting key challenges and recommendations for strengthening the UK’s response to this growing global crisis. The Society’s response was informed by the views of its members and the wider AMR community through its ‘Knocking Out AMR’ project.

AMR occurs when disease-causing bacteria, viruses, fungi and parasites (pathogens) are no longer affected by the medicines that have been developed to target them. Drug-resistant pathogens can cause infections that are difficult or impossible to treat; they increase the risk of disease spread and can lead to severe illness, disability and death.

The October 2024 edition of Microbiology Today is titled 'Emerging Opportunities.' This issue explores the use of bacteria to redefine our life on Earth and the role of microbes in space exploration. This issue looks at the opportunities microbiology provides for all of us.

In January 2024, the Microbiology Society hosted a series of solution-oriented, invite-only workshops dedicated to our priority solution areas: diagnostics, surveillance, therapeutics and vaccines. Read the full workshop reports here.

The May 2024 edition of Microbiology Today is titled 'Emerging Threats'. This issue explores threats from climate change to artificial intelligence, this issue explores a wide range of threats that microbiologists and the wider community face.

Last week, the UK Government published the latest five-year AMR National Action Plan (NAP) “Confronting Antimicrobial Resistance”, which aims to take the UK closer to reaching its vision of containing and controlling AMR by 2040.

Antimicrobial resistance (AMR) is a real and current threat to healthcare systems and economies across the world. Today, AMR is a leading cause of death worldwide, killing more people than HIV and malaria combined.

Human microbiome research is an exciting and dynamic field that has the potential to benefit many areas of our society and the economy. Microbiome research has progressed rapidly since the development of new genomic technologies and investment in large-scale, collaborative projects such as The Human Microbiome Project, a ten-year research initiative launched in 2007 which set out to characterise the human microbiome and its role in health and disease. Evidence from this project, alongside more recent studies, suggests that the findings from microbiome research can be used to improve human health.

The rise of antimicrobial resistance (AMR) is one of the most urgent global threats to public health in the 21st century. AMR refers to disease-causing microbes (also known as pathogens) evolving and gaining resistance to drugs and substances that were once effective treatments against infections (antimicrobials). It poses significant challenges to current clinical care, health economies, animal and plant health, as well as the environment. Microbiologists from across the world are committed to developing innovative solutions to combat AMR and reduce its impact on global health.

The rise of antimicrobial resistance (AMR) is one of the most urgent global threats to public health in the 21st century. AMR refers to disease-causing microbes (known as a pathogens) evolving and gaining resistance to drugs and substances that were once effective treatments against infections (antimicrobials). It poses significant challenges to clinical care, health economies, animal and plant health as well as the environment. Microbiologists from across the world are committed to developing innovative solutions to combat AMR.

The October 2023 edition of Microbiology Today is titled 'Knocking Out AMR'. This issue explores some of the challenges and most recent advancements within antimicrobial resistance (AMR) research.